Hjem › Alvorlig depressiv lidelse › Illinois › Chicago
Alvorlig depressiv lidelse kliniske forsøg i Chicago, IL
17 studier for Alvorlig depressiv lidelse søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
RekruttererFase 3
- Charter Research - Chicago, Chicago
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RekruttererFase 3
- Chicago Research Center, Chicago
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
RekruttererFase 3
- Northwestern University, Chicago
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RekruttererFase 2
- Chicago Research Center, Chicago
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RekruttererFase 3
- Rush University, Chicago
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RekruttererFase 3
- Vanda Investigational Site, Chicago
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
RekruttererFase 2
- Draig Clinical Site, Chicago
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Rekrutterer
- Rush University Medical Center, Chicago
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RekruttererFase 3
- Uptown Research Institute, Chicago
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
RekruttererFase 2
- EmVenio Research, Chicago
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
RekruttererFase 3
- Clinical Research Site, Chicago
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
RekruttererFase 2
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Rekrutterer
- University of Illinois at Chicago, Chicago
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RekruttererFase 2
- Pillar Clinical Research LLC, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
RekruttererObservationsstudie
- University of Chicago Medical Center, Chicago
Study of ALTO-300 in MDD
RekruttererFase 2
- Site 310, Chicago
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RekruttererFase 4
- Clinical Research Site, Chicago
Alvorlig depressiv lidelse forsøg i andre byer
- New York City, NY37 studier
- Boston, MA31 studier
- Atlanta, GA25 studier
- Philadelphia, PA23 studier
- Orlando, FL19 studier
- Miami, FL18 studier
- Tampa, FL17 studier
- Houston, TX16 studier
- San Diego, CA16 studier
- Little Rock, AR14 studier
- Orange, CA13 studier
- Austin, TX13 studier
Andre studier i Chicago
- Ikke-småcellet lungecancer61 studier
- Brystkræft58 studier
- Kræft (alle typer)51 studier
- Metastatisk cancer45 studier
- Prostatakræft45 studier
- Overvægt41 studier
- Lungecancer41 studier
- Ægstockræft36 studier
- Slagtilfælde34 studier
- Colorektal kræft33 studier
- Hjertesvigt31 studier
- Overvægt28 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.